Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 5/20 | 0.49 |
| ▸ | LOX | P28300 | 2/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.47 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.44 |
| ▸ | TTR | P02766 | 2/20 | 0.44 |
| ▸ | RHEB | Q15382 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15345331 | 0.79 | LOXL2 (0.44) | LOXL2LOXDPP4HRH1ST14 | |
| SCHEMBL2096411 | 0.78 | TTR (0.49) | TTRLTA4HTSHR | |
| SCHEMBL2096407 | 0.78 | TTR (0.41) | HRH1TTRLTA4HTSHRCYP1A2 | |
| SCHEMBL920863 | 0.77 | LOXL2 (0.53) | LOXL2LOXDPP4HRH1ST14 | |
| SCHEMBL17241842 | 0.77 | DPP4 (0.56) | LOXL2LOXDPP4HRH1ST14 | |
| SCHEMBL97008 | 0.74 | LTA4H (0.46) | HRH1TTRLTA4HTSHRCYP1A2 | |
| SCHEMBL30851410 | 0.73 | DPP4 (0.56) | LOXL2LOXDPP4TTRCYP1A2 | |
| SCHEMBL921313 | 0.73 | ROCK2 (0.50) | LOXL2LOXDPP4HRH1ST14 | |
| SCHEMBL16945359 | 0.73 | LOXL2 (0.49) | LOXL2LOXDPP4HRH1ST14 | |
| SCHEMBL121432 | 0.73 | ST14 (0.71) | LOXL2DPP4ST14LTA4HTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10711033-B2 | Branched chain-containing aromatic compound | AJINOMOTO CO., INC. (JP) | 2020-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10711033-B2 | Branched chain-containing aromatic compound | VIP, IAPP, BCAT1 | LOXL2 3217/4885LOX 2870/4885DPP4 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.